Juvenile idiopathic arthritis-associated uveitis

• Published in: Best practice & research. Clinical rheumatology Vol. 31; no. 4; pp. 517 - 534
• Main Authors: Sen, Ethan S., Ramanan, A.V.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.08.2017
• Subjects: Adalimumab; Biologics; Juvenile idiopathic arthritis; Tocilizumab; Uveitis; Adalimumab; Tocilizumab; Biologics; Uveitis; Juvenile idiopathic arthritis

Juvenile idiopathic arthritis (JIA) is the commonest rheumatic disease in children and JIA-associated uveitis its most frequent extra-articular manifestation. The uveitis is potentially sight-threatening and thus carries a considerable risk of morbidity with associated reduction in quality of life....